Forecyte Bio Limited

Forecyte Bio Limited is a CDMO company founded in 2021 to service the rapidly growing Cell and Gene Therapy (CGT) industry. Built on decades of experience and expertise from its core technical experts on CGT CMC processes, Forecyte Bio offers an integrated service package to accelerate CGT projects from early concept to IND filing and eventual commercial licensure and manufacturing. Our mission is to To accelerate patient access to gene and cell therapy with quality, speed, and agility. - Process Development to GMP production - Preclinical to Commercial scale - CMC documentation for IND and BLA - Variety of Products . Plasmid . Viral Vectors (AAV, AdV, Lenti, Oncolytic) . Cell processing (CAR-T, T-CRT, CAR-NK) - Extensive experience - Multiple Locations in US and China